Secor Capital Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-61,594
Closed -$3.95M 434
2018
Q4
$3.95M Buy
+61,594
New +$4.21M 0.52% 39
2018
Q3
Sell
-15,447
Closed -$1.13M 444
2018
Q2
$1.13M Buy
15,447
+2,938
+23% +$200K 0.1% 283
2018
Q1
$792K Buy
+12,509
New +$747K 0.07% 312
2017
Q2
Sell
-36,372
Closed -$1.61M 476
2017
Q1
$1.61M Buy
+36,372
New +$1.56M 0.18% 179
2016
Q2
Sell
-5,522
Closed -$232K 593
2016
Q1
$232K Sell
5,522
-5,727
-51% -$225K 0.03% 507
2015
Q4
$496K Buy
+11,249
New +$488K 0.14% 248
2015
Q1
Sell
-14,688
Closed -$660K 461
2014
Q4
$660K Buy
+14,688
New +$616K 0.28% 115
2014
Q2
Sell
-26,293
Closed -$1.14M 243
2014
Q1
$1.14M Buy
+26,293
New +$1.17M 0.56% 42

Other funds holding CNMD

Secor Capital Advisors's CNMD Position: Q1 2019 in Review

Secor Capital Advisors sold out of CONMED (CNMD) in Q1 2019, closing a stake of 61,594 shares — an estimated $3.95M sold.

Secor Capital Advisors first reported a position in CNMD in Q1 2014 and held it in 8 quarters. The position peaked at $3.95M in Q4 2018. 226 funds tracked by Wall St. Rank hold CNMD as of Q1 2019.

  • Secor Capital Advisors reported no remaining CONMED position as of Q1 2019 after selling out during the quarter.
  • Secor Capital Advisors sold 61,594 CONMED shares in Q1 2019, an estimated $3.95M.
  • Secor Capital Advisors first reported a position in CONMED in Q1 2014 and held it in 8 quarters.
  • Secor Capital Advisors's CONMED position peaked at $3.95M in Q4 2018.
  • 226 funds tracked by Wall St. Rank held CONMED as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.